Quanterix (QTRX) started trading on the Nasdaq on 7 December 2017

• HQ:  Billerica, Massachusetts
• Sector: Healthcare
• Industry: Biotechnology
• Full Time Employees: 177
• Incorporated in 2007
• http://www.quanterix.com

Quanterix (QTRX) raised $50 million in an initial public offering on Thursday, December 7th. The company issued 3,300,000 shares at a price of $14.00-$16.00 per share. In 2016, Quanterix generated $23 million in revenue and had a net loss of $31.4 million.

Quanterix Corporation, a life sciences company, develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Simoa HD-1 instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids.